Publications by authors named "Rodger A Allen"

Claim this Profile
P
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
Saba Nayar, Joana Campos, Charlotte G Smith, Valentina Iannizzotto, David H Gardner, Rodger A Allen

Ann Rheum Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K.
Rodger A Allen, Daniel C Brookings, Mark J Powell, Jean Delgado, Lindsay K Shuttleworth

J Pharmacol Exp Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037.
Emma J Haagensen, Huw D Thomas, Wolfgang A Schmalix, Andrew C Payne, Lara Kevorkian, Rodger A Allen

Cancer Chemother Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR direct interactions with Rheb-GTPase and raptor: sub-cellular localization using fluorescence lifetime imaging.
Rahul B Yadav, Pierre Burgos, Anthony W Parker, Valentina Iadevaia, Christopher G Proud, Rodger A Allen

BMC Cell Biol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting.
Christoph Meier, Daniel C Brookings, Thomas A Ceska, Carl Doyle, Haiping Gong, Rodger A Allen

J Struct Biol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fused thiophene derivatives as MEK inhibitors.
Victoria E Laing, Daniel C Brookings, Rachel J Carbery, Jose Gascon Simorte, Martin C Hutchings, Rodger A Allen

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential involvement of Galpha16 in CC chemokine-induced stimulation of phospholipase Cbeta, ERK, and chemotaxis.
Yaji Tian, Maggie M K Lee, Lisa Y Yung, Rodger A Allen, Patrick M Slocombe

Cell Signal· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
Emma L Wise, Cécile Duchesnes, Paula C A da Fonseca, Rodger A Allen, Timothy J Williams

J Biol Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
Yaji Tian, David C New, Lisa Y Yung, Rodger A Allen, Patrick M Slocombe

Eur J Immunol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis